Abstract Background Since 2022, the “13 en Santé” health mediation program has been implemented in Marseille, France, to reduce social health inequalities, in socioeconomically disadvantage neighbourhoods, with a particular emphasis on promoting participation in population-based organised cancer screening programs. Led by multidisciplinary teams including health mediators, nurses, coordinators, and volunteers, the intervention is structured around three core components: (i) territory exploration to develop knowledge of local communities and resources; (ii) culturally appropriate health education delivered through outreach activities to reach underserved populations; and (iii) individualised navigation support tailored to needs and level of autonomy. This study evaluates the effectiveness of this program in promoting breast, colorectal, and cervical cancer screening. Methods A controlled before-after design based on two cross-sectional knowledge-attitude-practice surveys was conducted in 2022 and 2024 in intervention or control neighbourhoods. Individuals aged 18–74 were randomly selected and interviewed via door-to-door questionnaires. Weighting was applied to account for stratified sampling and to align age and sex distributions with census data. For each cancer, weighted logistic regression models assessed associations between health mediation exposure and screening uptake and awareness at both individual and population levels. Results Overall, 4,523 individuals were included across the two cross-sectional surveys. The program successfully reached individuals facing cumulative socioeconomic barriers to healthcare access. No significant population-level association was observed between health mediation and cancer screening uptake or awareness. At the individual level, declared exposure to health mediation was associated with significantly higher uptakes of breast and colorectal cancer screenings (breast: 74% vs. 54%, OR = 2.3 [1.1–4.5]; colorectal: 50% vs. 30%, OR = 2.8 [1.3–5.8]). In addition, colorectal cancer screening awareness was significantly higher among exposed participants (93% vs. 83%, OR = 8.1 [2.1–31]). Conclusions This study provides the first evidence that reported individual exposure to a multicomponent health mediation intervention was significantly associated with an important increase in breast and colorectal cancer screening uptake in disadvantaged European neighbourhoods. Although the limitations of this observational study preclude causal conclusions regarding the intervention’s effectiveness, these findings suggest that health mediation may be a promising strategy for reducing inequalities in cancer prevention and warrant further investigation. It also highlights screening-specific mechanisms of action that should be considered to further optimise intervention effectiveness.
Background:Despite demonstrated virological efficacy, real-world evidence on the long-term effectiveness of dolutegravir plus lamivudine (DTG/3TC) in people living with HIV (PLWH) remains limited; this study assessed effectiveness, examining immunological response, resistance and safety. Methods:CARAVEL was a French, prospective, noninterventional, single-arm, multicenter, 3-year cohort study in treatment-naive PLWH (TN-PLWH) and pretreated PLWH (PT-PLWH) receiving DTG/3TC for the first time. Results:Forty-nine centers enrolled 304 participants: 56 TN-PLWH and 248 PT-PLWH. Effectiveness was evaluable in 49 (87%) TN-PLWH and 234 (94%) PT-PLWH. Initial virological suppression was attained for 44 (89.8%) TN-PLWH after 6 months of initiating DTG/3TC, with a median time to virological suppression of 1.1 months (IQR 1.0 to 2.1), and no virological failure during the follow-up. After switching, 220 (94%) PT-PLWH maintained virological suppression. During the follow-up, 14 PT-PLWH did not maintain virological suppression: 5 due to intermittent viraemia, and 9 due to virological failure (VF). Among the 9 participants with VF, a genotypic resistance test was available for 3 participants of whom 1 developed 3TC resistance [M184V] in the context of nonadherence. DTG/3TC was discontinued in 63 participants, mainly at their request (N = 40, 64.5%), as well as tolerability and VF. The average change in body weight over the follow-up was +2.0 (±6.0) (P = .13) kg in TN-PLWH and -0.2 (±6.5) (P = .78) kg in PT-PLWH, among participants with available data (N = 156). Conclusions:These real-world data demonstrated high virological success and good safety after up to 3 years on DTG/3TC in both TN-PLWH and PT-PLWH populations.
Dogs can detect volatile organic compounds (VOCs) associated with infectious diseases, but their ability to distinguish between symptomatic and asymptomatic SARS-CoV-2 infections has not been fully established. In this exploratory proof-of-concept study with a limited number of dogs, eight non-working dogs (without experience in scent detection) began training with either symptomatic or asymptomatic Delta samples; seven reached the testing phase and were then evaluated on the alternate group to assess cross-generalization. Training initially used a yes/no protocol but was adapted to a line-up design after poor performance. When presented with novel Delta samples from the other category, dogs significantly discriminated them from controls, achieving a mean sensitivity of 71% and a specificity of 51%, with no difference between training groups. In contrast, performance dropped when dogs were tested with a small number of asymptomatic Omicron-positive samples from vaccinated individuals, with a mean sensitivity of 35% and a specificity of 55%. Dogs can thus generalize across symptomatic and asymptomatic COVID-19 cases for the Delta variant; performance decreased for Omicron samples, likely due to altered VOC profiles in vaccinated individuals. While proof-of-concept feasibility was demonstrated with a line-up protocol for detecting asymptomatic scent, detection dogs should not currently be recommended for large-scale screening; the findings underscore the need for standardized protocols and variant-specific retraining.
To quantify differences of global and segmental sagittal thoracolumbar alignment between normal individuals and adolescent idiopathic scoliosis (AIS) according to primary curve types. Radiographic parameters were compared between 11161115 normal adolescents and young adults versus 17781779 AIS. Thoracic kyphosis (T1-T12), lumbar lordosis (L1-S1), segmental alignment (T1-T5, T5-T10), thoracolumbar junction (T10-L1), segmental lordosis (L1-L4, L4-S1), lumbar and thoracic apex, thoracolumbar inflection point, global alignment parameters (SVA C7, SVA C2, OD-HA, TPA, GT, SSA) and pelvic parameters (PI, PT, SS) were measured. C2 and C7 SVA was smaller and more posteriorly located in AIS compared to normal. Primary thoracic curves (Lenke 1, 2 and 3) had the lowest TK at T5-T10 compared to normal and primary thoracolumbar curves (Lenke 5 and 6). The thoracolumbar junction T10-L1 was smallest and slightly lordotic in Lenke 1 and 2. Distal lordosis L4-S1 and PI were highest in thoracolumbar curves (Lenke 3, 5 and 6). Thoracolumbar inflexion points, thoracic and lumbar apex were located more cranial in thoracic curves (Lenke 1 and 2) compared to normal and other AIS types. Thoracic curves (Lenke 1 and 2) were hypokyphotic in the distal thoracic segment T5-T10, had a neutral thoracolumbar junction T10-L1 and their apex and thoracolumbar junction were more cranial. Lenke 3 curves had an increased lordosis in the distal lumbar segment L4-S1. Primary lumbar curves (Lenke 5 and 6) had a higher PI and distal lordosis L4-S1, and the highest C7 SVA.